Floatz logo

Binimetinib

Stage IVA Rectal Cancer

University of California, San FranciscoSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Stage IVA Rectal Cancer cohort.

Asset / SponsorPhaseRating
Cediranib
National Cancer Institute (NCI)
Phase 2BBB
Dfn-15
University of Washington
Phase 2CCC
Nintedanib
Roswell Park Cancer Institute
Phase 1/2CCC

Same molecule, other indications

Binimetinib is also rated in:

metastatic malignant neoplasm in the colonDormant
BB
Indicative ·
70 / 100
View asset →
cutaneous melanomaDormant
BB
Indicative ·
68 / 100
View asset →
triple-negative breast carcinomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →